Mediplantex National Pharmaceutical JSC
VN:MED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1), the stock would be worth ₫27 608.64 (1% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1 | ₫27 800 |
0%
|
| 3-Year Average | 1 | ₫27 608.64 |
-1%
|
| 5-Year Average | 1 | ₫27 633.69 |
-1%
|
| Industry Average | 2.2 | ₫59 799.26 |
+115%
|
| Country Average | 1.7 | ₫44 975.38 |
+62%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| VN |
M
|
Mediplantex National Pharmaceutical JSC
VN:MED
|
345B VND | 1 | 22.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
825.8B USD | 31.1 | 40 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
548.5B USD | 6.7 | 26.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 7.7 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.6B GBP | 5.9 | 27.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
218.9B CHF | 5.9 | 19.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.3B USD | 5.2 | 14.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | -58.7 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 6.1 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
150.6B USD | 1.7 | 19.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.3B USD | 6.3 | 16.6 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 1.3 |
| Median | 1.7 |
| 70th Percentile | 2.2 |
| Max | 16.4 |
Other Multiples
Mediplantex National Pharmaceutical JSC
Glance View
Mediplantex National Pharmaceutical JSC engages in the manufacture and sale of pharmaceutical products and raw materials. The company is headquartered in Hanoi, Hanoi. The company went IPO on 2020-03-18. The firm is engaged in the manufacturing of pharmaceutical products, including various types of pharmaceutical preparations and medicinal and botanical preparations, as well as herb farming. Besides, it is involved in the import, export and wholesale and retail trading of pharmaceutical products through its drug stores. The firm is also investing in real estate projects so as to lease offices, apartments and warehouse.
